Skip to main content
. 2020 Dec 17;10:22190. doi: 10.1038/s41598-020-79102-7

Figure 1.

Figure 1

Experimental design. C57BL/6 mice received daily oral doses of Saccharomyces cerevisiae or selenium-enriched yeast (Selemax) for 14 days starting on EAE induction (a). Body weight and clinical score were assessed daily for 15 days. On the 15th day, which corresponded to the acute disease phase, fresh stools were collected for metagenomic sequencing and the animals were then euthanized (arrow). Samples from gut-brain axis and peripheral lymphoid organs were collected to evaluate immunological parameters (b). The mRNA expression and cytokine levels were assessed on CNS (brain plus spinal cord) whereas inflammatory infiltration and demyelination were assessed on lumbar spinal cord. Inflammatory infiltration, mRNA expression and cytokine levels were assessed on small intestine and the proportion of T cells and dendritic cells subsets were evaluated in mesenteric lymph nodes. Peripheral immunological parameters as T cell and cytokine levels were evaluated in inguinal lymph nodes and spleen, respectively. This figure was created using images from Servier Medical Art Commons Attribution 3.0 Unported License (https://smart.servier.com) and image was modified with Adobe Photoshop v.22.0.0.